ARTICLE | Company News
Augurex Life Sciences Corp., Quest Diagnostics deal
October 15, 2012 7:00 AM UTC
Quest received an exclusive license for the development of a clinical testing service to diagnose rheumatoid arthritis (RA) in the U.S. based on Augurex's RA 14-3-3n biomarker. Quest plans to launch t...